Suchergebnisse - "Lopinavir"

PubPharm (372)

1

Evaluation of the efficacy and safety of oral N-acetylcysteine in patients with COVID-19 receiving the routine antiviral and hydroxychloroquine protocol : A randomized controlled clinical trial

enthalten in: Immunity, inflammation and disease | 2023

von Atefi, N. | Goodarzi, A. | Riahi, T. | +7

2

Genetic variations of CYP3A4 on the metabolism of itraconazole in vitro

enthalten in: Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association | 2023

von Xie, S. | Zhu, X. | Gao, N. | +6

3

Twenty-eight-day mortality among patients with severe or critical COVID-19 in Hong Kong during the early stages of the pandemic

enthalten in: Hong Kong medical journal = Xianggang yi xue za zhi | 2023

von Chan, A. | Lung, K. | Yu, J. | +2

4

Risk Factors for the Prescription of Ineffective Antiviral Candidates for COVID-19 During the Early Pandemic Period in Korea

enthalten in: Journal of Korean medical science | 2023

von Lee, E. | Kim, S. | Lee, S. | +7

5

Pharmacovigilance follow-up of patients in the context of the COVID-19 pandemic

enthalten in: Therapie | 2023

von Grandvuillemin, A. | Rocher, F. | Valnet-Rabier, M. | +3

6

Safety profile of the lopinavir/ritonavir combination before and during the SARS-CoV-2 pandemic

enthalten in: Therapie | 2023

von Lory, P. | Combret, S. | Michot, J. | +3

7

A Comparative Study of Antiretroviral (Lopinavir/Ritonavir) and Remdesivir Used in the Pandemic in Iraq on the Clinical Outcome in Patients with SARS-CoV-2

enthalten in: Archives of Razi Institute | 2023

von Alabdalaali, M. | Hadi, A.

8

Systemic Review and Meta-Analysis to Evaluate Therapeutic Effectiveness of Interferon Beta-1b in Hospitalized COVID-19 Patients

enthalten in: Indian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine | 2023

von Nayudu, G. | Benny, M. | Thomas, G. | +2

9

Crushing lopinavir/ritonavir tablets does not result in lower exposure to lopinavir/ritonavir in adult patients with COVID-19

enthalten in: European journal of hospital pharmacy : science and practice | 2023

von Mohsenian Naghani, S. | Jansen, M. | Jaspers, T. | +2

10

Electronic monitoring of potential adverse drug events related to lopinavir/ritonavir and hydroxychloroquine during the first wave of COVID-19

enthalten in: European journal of hospital pharmacy : science and practice | 2023

von Skalafouris, C. | Samer, C. | Stirnemann, J. | +6

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[38]